Table 1 Characteristics of 94 patients with Ewing sarcoma and 72 patients with osteosarcoma with available ctDNA results

From: Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group

 

Ewing sarcoma cohort (n = 94)

Osteosarcoma cohort (n = 72)

Sex

 Male

53 (56.4)

46 (63.9)

 Female

41 (43.6)

26 (36.1)

Age at diagnosis, years (median, range)

14.1 (1.9–20.6)a

13.6 (5.6–22.4)

Primary disease site

Pelvic

20 (26.3)b

 

Non-pelvic

56 (73.7)

Femur

 

31 (43.1)

Tibia

24 (33.3)

Humerus

8 (11.1)

Fibula

5 (6.9)

Other

4 (5.6)

Stage at diagnosis

Localised

52 (63.4)c

72 (100)

Metastatic

30 (36.6)

0 (0)

Time of sample acquisition

Initial diagnosis

77 (81.9)

72 (100)

Relapse

17 (18.1)

0 (0)

  1. aAge at diagnosis available for 77 patients with newly diagnosed disease.
  2. bPrimary site data available for 76 patients with Ewing sarcoma.
  3. cStage at diagnosis available for 82 patients with Ewing sarcoma